| Literature DB >> 22177233 |
Yangyang Liu1, Hanying Zhang, Chuanling Qiao, Xiping Lu, Feng Cui.
Abstract
BACKGROUND: In China, large amounts of chemical insecticides are applied in fields or indoors every year, directly or indirectly bringing selection pressure on vector mosquitoes. Culex pipiens complex has evolved to be resistant to all types of chemical insecticides, especially organophosphates, through carboxylesterases. Six resistant carboxylesterase alleles (Ester) were recorded previously and sometimes co-existed in one field population, representing a complex situation for the evolution of Ester genes.Entities:
Mesh:
Substances:
Year: 2011 PMID: 22177233 PMCID: PMC3259124 DOI: 10.1186/1756-3305-4-236
Source DB: PubMed Journal: Parasit Vectors ISSN: 1756-3305 Impact factor: 3.876
Collection information of Culex pipiens pallens sampled in China.
| Province | Locality (latitude, longitude) | Code | Date | Type of sites |
|---|---|---|---|---|
| Henan | Weihe (35°02' N, 113°8' E) | WHE | 15/07/2010 | sewage tank |
| Yuanyang (35°02' N, 113°58' E) | YUY | 14/07/2010 | cesspool | |
| Shandong | Taian (35°38' N, 116°2' E) | TAA | 24/07/2010 | puddle |
| Beijing | Beijing (39°54' N, 116°28' E) | BJI | 29/07/2010 | sewage |
| Liaoning | Pulandian (39°23' N, 121°58' E) | LPU | 20/07/2010 | puddle |
Resistance observed in bioassays to seven insecticides in five populations of Culex pipiens pallens from China.
| Insecticides | Populations | N | LC50 (95% CI) (mg/L) | Slope (SE) | χ2 | RR (95% CI) | G |
|---|---|---|---|---|---|---|---|
| Dichlorvos | S-LAB | 300 | 0.19 (0.18-0.19) | 13.8 (1.6) | 1.7 | 1 | F2 |
| WHE | 240 | 3.04 (2.86-3.17) | 8.0 (1.3) | 4.8 | 16.4 (12.3-21.7) | F1 | |
| YUY | 240 | 3.86 (3.22-4.07) | 11.1 (3.4) | 0.5 | 20.8 (13.4-32.3) | F1 | |
| TAA | 300 | 2.91 (2.11-3.27) | 5.2 (1.4) | 0.4 | 15.7 (10.2-24.3) | F2 | |
| BJI | 300 | 1.26 (1.19-1.33) | 9.7 (1.3) | 1.6 | 6.8 (4.9-9.4) | F2 | |
| LPU | 300 | 1.06 (0.88-1.14) | 7.4 (2.3) | 1.6 | 5.7 (3.9-8.3) | F2 | |
| Fenitrothion | S-LAB | 300 | 0.0078 (0.0076-0.0081) | 15.8 (1.8) | 5.2 | 1 | F2 |
| WHE | 300 | 0.015 (0.014-0.016) | 6.8 (1.6) | 2.3 | 1.9 (1.4-2.6) | F1 | |
| YUY | 360 | 0.0099 (0.0084-0.011) | 4.0 (0.9) | 0.4 | 1.3 (0.9-1.7) | F1 | |
| TAA | 240 | 0.020 (0.018-0.022) | 6.6 (1.7) | 1.5 | 2.5 (1.8-3.6) | F1 | |
| BJI | 300 | 0.0096 (0.0088-0.010) | 5.6 (0.7) | 0.8 | 1.2 (0.9-1.6) | F2 | |
| LPU | 300 | 0.015 (0.014-0.016) | 6.9 (1.0) | 0.6 | 1.9 (1.4-2.6) | F2 | |
| Malathion | S-LAB | 240 | 0.025 (0.020-0.030) | 12.0 (4.1) | 7.3 | 1 | F2 |
| WHE | 360 | 0.094 (0.089-0.099) | 7.4 (0. 8) | 2.2 | 3.8 (1.8-8.0) | F2 | |
| YUY | 360 | 0.073 (0.069-0.076) | 6.8 (1.6) | 2.3 | 3.0 (1.4-6.2) | F1 | |
| TAA | 300 | 0.080 (0.073-0.086) | 6.9 (1.5) | 3.0 | 3.3 (1.4-7.8) | F1 | |
| BJI | 300 | 0.073 (0.066-0.081) | 4.1 (0.6) | 3.9 | 3.0 (1.4-6.3) | F2 | |
| LPU | 240 | 0.052 (0.044-0.062) | 3.7 (0.6) | 1.4 | 2.1 (0.9-5.2) | F2 | |
| Deltamethrin | S-LAB | 300 | 0.00039 (0.00036-0.00043) | 5.3 (1.1) | 0.3 | 1 | F2 |
| WHE | 360 | 0.0026 (0.0021-0.0029) | 4.1 ( 0.9 ) | 6.0 | 6.6 (4.9-8.7) | F2 | |
| YUY | 360 | 0.0046 (0.0022-0.0054) | 3.8 ( 1.3 ) | 0.05 | 11.7 (7.4-18.1) | F1 | |
| TAA | 240 | 0.0039 (0.0029-0.0046) | 2.3 (0.5) | 0.4 | 9.9 (7.4-12.9) | F2 | |
| BJI | 300 | 0.0023 (0.0020-0.0024) | 5.8 (1.4) | 0.004 | 5.8 (4.3-7.6) | F2 | |
| LPU | 240 | 0.0014 (0.0007-0.0017) | 3.8 (1.1) | 0.01 | 3.5 (2.1-5.9) | F2 | |
| Permethrin | S-LAB | 300 | 0.0017 (0.0016-0.0019) | 5.6 (0.6) | 4.8 | 1 | F2 |
| WHE | 300 | 0.038 (0.035-0.041) | 9.4 (1.8) | 0.4 | 21.9 (15.6-30.5) | F2 | |
| YUY | 300 | 0.055 (0.043-0.062) | 3.8 (0.9) | 2.1 | 31.9 (22.9-43.9) | F1 | |
| TAA | 300 | 0.12 ( 0.04-0.17 ) | 1.4 (0.4) | 0.2 | 68.2 (46.9-99.0) | F2 | |
| BJI | 360 | 0.024 (0.023-0.025) | 11.0 (1.8) | 2.0 | 13.8 (10.3-18.5) | F2 | |
| LPU | 240 | 0.016 (0.011-0.021) | 2.0 (0.6) | 0.4 | 9.5 (6.9-12.9) | F3 | |
| Propoxur | S-LAB | 300 | 0.13 (0.13-0.14) | 9.7 (1.4) | 0.6 | 1 | F2 |
| WHE | 300 | 0.28 (0.26-0.31) | 7.1 (1.6) | 1.2 | 2.1 (1.5-2.9) | F2 | |
| YUY | 300 | 0.18 (0.09-0.21) | 4.9 (1.6) | 1.6 | 1.3 (0.8-2.3) | F1 | |
| TAA | 300 | 0.27 (0.25-0.28) | 9.7 (1.4) | 0.2 | 2.0 (1.5-2.7) | F2 | |
| BJI | 300 | 0.23 (0.21-0.25) | 8.5 (2.1) | 0.1 | 1.8 (1.3-2.5) | F2 | |
| LPU | 300 | 0.21 (0.19-0.23) | 6.5 (2.0) | 0.3 | 1.6 (1.2-2.1) | F2 | |
| BPMC | S-LAB | 300 | 0.097 ( 0.025-0.35 ) | 10.8 (3.8) | 6.2 | 1 | F2 |
| WHE | 360 | 0.39 (0.36-0.42) | 7.7 (2.1) | 3.5 | 4.0 (0.9-17.7) | F2 | |
| YUY | 240 | 0.23 (0.17-0.26) | 3.5 (0.7) | 4.5 | 2.3 (0.8-7.2) | F1 | |
| TAA | 240 | 0.42 (0.39-0.44) | 12.7 (2.6) | 0.2 | 4.3 (1.0-19.2) | F2 | |
| BJI | 300 | 0.34 (0.31-0.35) | 8.9 (1.4) | 0.4 | 3.4 (1.2-10.2) | F2 | |
| LPU | 300 | 0.21 (0.16-0.24) | 3.9 (1.0) | 0.2 | 2.1 (0.5-9.6) | F3 |
S-LAB, the susceptible reference strain. N, number of larvae tested. CI, confidence interval. RR, resistance ratio (LC50 of the population/LC50 of S-LAB). G, the generation considered in bioassays.
Frequency* of mosquitoes displaying a given overproduced esterase in field populations of Culex pipiens pallens in China
| Population code | N | B1 | A2-B2 | A8-B8 | A9-B9 | B10 | A11-B11 | SS |
|---|---|---|---|---|---|---|---|---|
| WHE | 35 | 0.83 | 0 | 0 | 0.09 | 0.06 | 0.03 | 0.06 |
| YUY | 41 | 0.88 | 0.2 | 0.05 | 0 | 0 | 0 | 0.17 |
| TAA | 45 | 0.98 | 0.04 | 0 | 0 | 0 | 0 | 0.02 |
| BJI | 36 | 0.72 | 0.03 | 0 | 0 | 0 | 0 | 0.25 |
| LPU | 43 | 0.56 | 0.14 | 0 | 0 | 0 | 0 | 0.33 |
* The sum of phenotypic frequency in each population is not necessarily equal to 1, considering some individuals are heterozygous with two overproduced esterases.
N, the sample size analyzed. SS, the non-overproduced esterase phenotype.
Figure 1High-activity esterases in single adult mosquitoes from the five populations analyzed in starch electrophoresis. High-activity esterases in single adult mosquitoes from the five populations analyzed in starch electrophoresis. Only part of the gel for each population was shown. SB1 and SA2 were the standard strains displaying overproduced esterase B1 and A2-B2, respectively. SS means susceptible individuals.
Figure 2Correlations between esterase frequencies and resistance ratios to chlorpyrifos. Correlations between esterase frequencies and resistance ratios to chlorpyrifos (a), parathion (b), dichlorvos (c) and propoxur (d).
Figure 3Correlations among frequencies of various esterases. Correlations among frequencies of various esterases. (a) between A8-B8 and A9-B9, A8-B8 and B10, and A8-B8 and B1; (b) between A9-B9 and B10.